SCHEMBL9655016

SCHEMBL9655016

Cc1ccc(C=NN)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367520 0.79
SCHEMBL7349985 0.77
SCHEMBL7349983 0.77
SCHEMBL10920917 0.77
SCHEMBL16101744 0.76 ALDH1A1 (0.77)
SCHEMBL16101747 0.76 ALDH1A1 (0.77)
SCHEMBL4545366 0.74 CYP1A2 (0.49)
SCHEMBL14572061 0.74 KMT2A (0.49)
SCHEMBL20878192 0.73 MEN1 (0.64)
SCHEMBL3973171 0.72 G6PC1 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299974-B1 ANTHELMINTIC ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1992-01-22 EP claimed
EP-0299974-A1 ANTHELMINTIC ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS. UPJOHN CO (US) 1989-01-25 EP claimed
WO-1987006127-A1 ANTHELMINTIC ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1987-10-22 WO claimed
US-11591569-B2 Methods for epicardial differentiation of human pluripotent stem cells WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2023-02-28 US disclosed
US-11352604-B2 Method of making cardiomyocytes from human pluripotent cells WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2022-06-07 US disclosed
EP-3519559-A1 PRIMED CARDIAC PROGENITORS AND METHODS FOR MAKING AND USING SAME Wisconsin Alumini Research Foundation (US) 2019-08-07 EP disclosed
US-20190085293-A1 METHODS FOR EPICARDIAL DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS WISCONSIN ALUMNI RESEARCH FOUNDATION 2019-03-21 US disclosed
US-10131878-B2 Methods for epicardial differentiation of human pluripotent stem cells WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-11-20 US disclosed
US-20180094246-A1 Primed Cardiac Progenitors and Methods for Making and Using Same WISCONSIN ALUMNI RESEARCH FOUNDATION 2018-04-05 US disclosed
WO-2018064580-A1 PRIMED CARDIAC PROGENITORS AND METHODS FOR MAKING AND USING SAME WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-04-05 WO disclosed
US-9663764-B2 Generation of cardiomyocytes from human pluripotent stem cells WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2017-05-30 US disclosed
US-20160068814-A1 CHEMICALLY DEFINED ALBUMIN-FREE CONDITIONS FOR CARDIOMYOCYTE DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-03-10 US disclosed
US-20150368411-A1 POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME AVERTICA INC. 2015-12-24 US disclosed
US-20150152389-A1 GENERATION OF CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-06-04 US disclosed
US-8951798-B2 Generation of cardiomyocytes from human pluripotent stem cells WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-02-10 US disclosed
US-20130189785-A1 GENERATION OF CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS WISCONSIN ALUMNI RESEARCH FOUNDATION 2013-07-25 US disclosed
WO-2013056072-A1 GENERATION OF CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-04-18 WO disclosed
EP-0299974-B1 ANTHELMINTIC ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1992-01-22 EP disclosed
EP-0299974-A1 ANTHELMINTIC ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS. UPJOHN CO (US) 1989-01-25 EP disclosed
WO-1987006127-A1 ANTHELMINTIC ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1987-10-22 WO disclosed